{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "09",
                "@year": "2023",
                "@timestamp": "2023-07-09T18:44:42.000042-04:00",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2019",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "Bayer",
                    "xocs:funding-agency": "Bayer",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004326",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2921044/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis",
                    "xocs:funding-agency": "Novartis",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004336",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "MET",
                    "xocs:funding-agency": "Metropolitan Museum of Art",
                    "xocs:funding-id": "INC280",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100005807",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Celgene",
                    "xocs:funding-agency": "Celgene",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100006436",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Shire",
                    "xocs:funding-agency": "Shire",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100007343",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis Pharmaceuticals Corporation",
                    "xocs:funding-agency-acronym": "NPC",
                    "xocs:funding-agency": "Novartis Pharmaceuticals Corporation",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008272",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "BMS",
                    "xocs:funding-agency-acronym": "BMS",
                    "xocs:funding-agency": "British Microcirculation Society",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100000555",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Eisai",
                    "xocs:funding-agency": "Eisai",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100003769",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1861060/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-11-15T10:19:47.169Z",
            "xocs:funding-text": "Supplemental material, INC280X2201_HCC_Manuscript_Supplementary_Table_S4 for A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma by Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, Guohong Han, Su Pin Choo, Virote Sriuranpong, Hongming Pan, Thomas Yau, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Luigi Manenti, Yi Gu, Yongjian Sun, Ralph Tiedt, Lu Hao, Wenjie Song and Tawesak Tanwandee in Therapeutic Advances in Medical Oncology Medical writing and editorial support for this manuscript was provided by Matthew Naylor PhD of Articulate Science and funded by Novartis Pharmaceuticals Corporation. Author note This study was presented in part at American Society of Clinical Oncology (ASCO), Chicago, IL, USA, 3\u20137 June 2016 (Poster Abstract 4074). Funding The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support for this study was provided by Novartis Pharmaceuticals Corporation. Conflict of interest statement Su Pin Choo received funding, nonfinancial support, and honoraria from BMS, nonfinancial support and honoraria from Bayer, and honoraria from Novartis, Shire, Sirtex, Eisai, and Celgene. Virote Sriuranpong has received research support from Novartis. Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, Guohong Han, Hongming Pan, Thomas Yau, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, and Tawesak Tanwandee have no competing financial interests. Yi Gu, Yongjian Sun, Lu Hao, and Wenjie Song are employees of Novartis. Luigi Manenti and Ralph Tiedt are employees of Novartis and hold stock with Novartis. Supplemental material Supplemental material for this article is available online.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "China",
                            "postal-code": "210002",
                            "@afid": "100642684",
                            "@country": "chn",
                            "city": "Nanjing",
                            "organization": [
                                {"$": "PLA Cancer Center"},
                                {"$": "Nanjing Bayi Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "100642684",
                                "@dptid": "108599727"
                            },
                            "@affiliation-instance-id": "2003855381-2e8294cf0a174acd410e03d168efe528",
                            "ce:source-text": "PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, 210002, China",
                            "@dptid": "108599727"
                        },
                        "author": [{
                            "ce:given-name": "Shukui",
                            "preferred-name": {
                                "ce:given-name": "Shukui",
                                "ce:initials": "S.",
                                "ce:surname": "Qin",
                                "ce:indexed-name": "Qin S."
                            },
                            "@seq": "1",
                            "@author-instance-id": "2003855381-2c37030334e0059a10c5d9c878353810",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Qin",
                            "@auid": "57217457374",
                            "ce:indexed-name": "Qin S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60024787",
                            "@country": "hkg",
                            "organization": [
                                {"$": "Department of Clinical Oncology"},
                                {"$": "Chinese University of Hong Kong"},
                                {"$": "Prince of Wales Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60024787",
                                    "@dptid": "113298622"
                                },
                                {"@afid": "60002798"}
                            ],
                            "@affiliation-instance-id": "2003855381-4c8db31b1e187e729911a234d49b0854",
                            "ce:source-text": "Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China",
                            "@dptid": "113298622"
                        },
                        "author": [{
                            "ce:given-name": "Stephen Lam",
                            "preferred-name": {
                                "ce:given-name": "Stephen Lam",
                                "ce:initials": "S.L.",
                                "ce:surname": "Chan",
                                "ce:indexed-name": "Chan S.L."
                            },
                            "@seq": "2",
                            "@author-instance-id": "2003855381-e71ab94536deaa3631f74579a0cce8f8",
                            "ce:initials": "S.L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chan",
                            "@auid": "34973871600",
                            "ce:indexed-name": "Chan S.L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60017165",
                            "@country": "tha",
                            "city": "Khon Kaen",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Srinagarind Hospital"},
                                {"$": "Khon Kaen University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60017165",
                                    "@dptid": "112983025"
                                },
                                {"@afid": "60021909"}
                            ],
                            "@affiliation-instance-id": "2003855381-f803783dbdda48b80b7e3eba716abd1f",
                            "ce:source-text": "Department of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand",
                            "@dptid": "112983025"
                        },
                        "author": [{
                            "ce:given-name": "Wattana",
                            "preferred-name": {
                                "ce:given-name": "Wattana",
                                "ce:initials": "W.",
                                "ce:surname": "Sukeepaisarnjaroen",
                                "ce:indexed-name": "Sukeepaisarnjaroen W."
                            },
                            "@seq": "3",
                            "@author-instance-id": "2003855381-b5d0f32ffe624989852766c2c2be948d",
                            "ce:initials": "W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sukeepaisarnjaroen",
                            "@auid": "6505802234",
                            "ce:indexed-name": "Sukeepaisarnjaroen W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60069708",
                            "@country": "chn",
                            "city": "Xi\u2019an",
                            "organization": [
                                {"$": "Department of Liver Disease and Digestive Interventional Radiology"},
                                {"$": "Xijing Hospital of Digestive Diseases"},
                                {"$": "Fourth Military Medical University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60069708",
                                    "@dptid": "114491725"
                                },
                                {"@afid": "60088187"}
                            ],
                            "@affiliation-instance-id": "2003855381-d8e2f0acb2bdc63a42c584fb064d952b",
                            "ce:source-text": "Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi\u2019an, China",
                            "@dptid": "114491725"
                        },
                        "author": [{
                            "ce:given-name": "Guohong",
                            "preferred-name": {
                                "ce:given-name": "Guohong",
                                "ce:initials": "G.",
                                "ce:surname": "Han",
                                "ce:indexed-name": "Han G."
                            },
                            "@seq": "4",
                            "@author-instance-id": "2003855381-31eec7776380a194bfa2c13c410fcbfc",
                            "ce:initials": "G.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Han",
                            "@auid": "24741087200",
                            "ce:indexed-name": "Han G."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60031809",
                            "@country": "sgp",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "National Cancer Center Singapore"}
                            ],
                            "affiliation-id": {
                                "@afid": "60031809",
                                "@dptid": "104614771"
                            },
                            "@affiliation-instance-id": "2003855381-f6b0c1a3c8917921d0e02f9442e454d6",
                            "ce:source-text": "Division of Medical Oncology, National Cancer Center Singapore, Singapore",
                            "@dptid": "104614771"
                        },
                        "author": [{
                            "ce:given-name": "Su Pin",
                            "preferred-name": {
                                "ce:given-name": "Su Pin",
                                "ce:initials": "S.P.",
                                "ce:surname": "Choo",
                                "ce:indexed-name": "Choo S.P."
                            },
                            "@seq": "5",
                            "@author-instance-id": "2003855381-47b954c576346e29c0b0a94d703cee74",
                            "ce:initials": "S.P.",
                            "@date-locked": "2020-10-31T22:32:02.221",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Choo",
                            "@auid": "12446713500",
                            "ce:indexed-name": "Choo S.P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@affiliation-instance-id": "2003855381-fb5d137732b552a635dc1c17bcd283e1",
                            "ce:source-text": "Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Virote",
                            "preferred-name": {
                                "ce:given-name": "Virote",
                                "ce:initials": "V.",
                                "ce:surname": "Sriuranpong",
                                "ce:indexed-name": "Sriuranpong V."
                            },
                            "@seq": "6",
                            "@author-instance-id": "2003855381-fa5746e02a05e3b7ef91a4cf8096b999",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sriuranpong",
                            "@auid": "6603599644",
                            "ce:indexed-name": "Sriuranpong V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60118427",
                            "@country": "chn",
                            "city": "Hangzhou",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Sir Run Shaw Hospital"},
                                {"$": "Zhejiang University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60118427",
                                    "@dptid": "122946271"
                                },
                                {"@afid": "60003970"}
                            ],
                            "@affiliation-instance-id": "2003855381-eee0405d87e8672dc241d93aeefa6280",
                            "ce:source-text": "Department of Medical Oncology, Sir Run Shaw Hospital, Zhejiang University, Hangzhou, China",
                            "@dptid": "122946271"
                        },
                        "author": [{
                            "ce:given-name": "Hongming",
                            "preferred-name": {
                                "ce:given-name": "Hongming",
                                "ce:initials": "H.",
                                "ce:surname": "Pan",
                                "ce:indexed-name": "Pan H."
                            },
                            "@seq": "7",
                            "@author-instance-id": "2003855381-f4b691378b56b5d47e8724c86467c198",
                            "ce:initials": "H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pan",
                            "@auid": "57202595746",
                            "ce:indexed-name": "Pan H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60006541",
                            "@country": "hkg",
                            "organization": [
                                {"$": "Department of Surgery"},
                                {"$": "Queen Mary Hospital"},
                                {"$": "University of Hong Kong"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60006541",
                                    "@dptid": "113555398"
                                },
                                {"@afid": "60033020"}
                            ],
                            "@affiliation-instance-id": "2003855381-586e4e05828ab3b491fa7f6e257cc2b6",
                            "ce:source-text": "Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong",
                            "@dptid": "113555398"
                        },
                        "author": [{
                            "ce:given-name": "Thomas",
                            "preferred-name": {
                                "ce:given-name": "Thomas",
                                "ce:initials": "T.",
                                "ce:surname": "Yau",
                                "ce:indexed-name": "Yau T."
                            },
                            "@seq": "8",
                            "@author-instance-id": "2003855381-75167cd5c690f81dd4e241ca8e9f0a0d",
                            "ce:initials": "T.",
                            "@date-locked": "2021-04-09T07:46:08.317",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yau",
                            "@auid": "23391533100",
                            "ce:indexed-name": "Yau T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60002593",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": [
                                {"$": "Nanfang Hospital"},
                                {"$": "Guangzhou Southern Medical University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60002593"},
                                {"@afid": "60043314"}
                            ],
                            "@affiliation-instance-id": "2003855381-842e7c838401dee0d942172cd5363280",
                            "ce:source-text": "Nanfang Hospital, Guangzhou Southern Medical University, Guangzhou, China"
                        },
                        "author": [{
                            "ce:given-name": "Yabing",
                            "preferred-name": {
                                "ce:given-name": "Yabing",
                                "ce:initials": "Y.",
                                "ce:surname": "Guo",
                                "ce:indexed-name": "Guo Y."
                            },
                            "@seq": "9",
                            "@author-instance-id": "2003855381-3946670946fcd011c051710bf02b0f5c",
                            "ce:initials": "Y.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Guo",
                            "@auid": "55612247400",
                            "ce:indexed-name": "Guo Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60082502",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": {"$": "Sun Yat-Sen University Cancer Center"},
                            "affiliation-id": {"@afid": "60082502"},
                            "@affiliation-instance-id": "2003855381-65f496dc1733b289fa55f8f07879e832",
                            "ce:source-text": "Sun Yat-Sen University Cancer Center, Guangzhou, China"
                        },
                        "author": [{
                            "ce:given-name": "Minshan",
                            "preferred-name": {
                                "ce:given-name": "Minshan",
                                "ce:initials": "M.",
                                "ce:surname": "Chen",
                                "ce:indexed-name": "Chen M."
                            },
                            "@seq": "10",
                            "@author-instance-id": "2003855381-a76673b3728d0bf5f47bbffae4840f4d",
                            "ce:initials": "M.",
                            "@date-locked": "2020-04-16T12:22:24.996",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chen",
                            "@auid": "24333976200",
                            "ce:indexed-name": "Chen M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60009860",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "Liver Cancer Institute"},
                                {"$": "Zhongshan Hospital"},
                                {"$": "Fudan University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60009860",
                                    "@dptid": "103537080"
                                },
                                {"@afid": "60073655"}
                            ],
                            "@affiliation-instance-id": "2003855381-63e3f652de901340c59a9d07a5f22def",
                            "ce:source-text": "Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China",
                            "@dptid": "103537080"
                        },
                        "author": [{
                            "ce:given-name": "Zhenggang",
                            "preferred-name": {
                                "ce:given-name": "Zhenggang",
                                "ce:initials": "Z.",
                                "ce:surname": "Ren",
                                "ce:indexed-name": "Ren Z."
                            },
                            "@seq": "11",
                            "@author-instance-id": "2003855381-208303b3177e2326f915aa9c3bc1af03",
                            "ce:initials": "Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ren",
                            "@auid": "7402408571",
                            "ce:indexed-name": "Ren Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60088470",
                            "@country": "chn",
                            "city": "Beijing",
                            "organization": [
                                {"$": "Department of Gastrointestinal Oncology"},
                                {"$": "307 Hospital of People\u2019s Liberation Army"}
                            ],
                            "affiliation-id": {
                                "@afid": "60088470",
                                "@dptid": "114115418"
                            },
                            "@affiliation-instance-id": "2003855381-8566a5e852276b342c71cf76bdbd99b3",
                            "ce:source-text": "Department of Gastrointestinal Oncology, 307 Hospital of People\u2019s Liberation Army, Beijing, China",
                            "@dptid": "114115418"
                        },
                        "author": [{
                            "ce:given-name": "Jianming",
                            "preferred-name": {
                                "ce:given-name": "Jianming",
                                "ce:initials": "J.",
                                "ce:surname": "Xu",
                                "ce:indexed-name": "Xu J."
                            },
                            "@seq": "12",
                            "@author-instance-id": "2003855381-da3c6c0c9b45ee172ce3520707720877",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Xu",
                            "@auid": "57196733111",
                            "ce:indexed-name": "Xu J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60073386",
                            "@country": "twn",
                            "city": "Tainan City",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "National Cheng Kung University Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60073386",
                                "@dptid": "113739517"
                            },
                            "@affiliation-instance-id": "2003855381-702bfbffeedfd1681f25eadf4ad4243b",
                            "ce:source-text": "Department of Internal Medicine, National Cheng Kung University Hospital, Tainan City",
                            "@dptid": "113739517"
                        },
                        "author": [{
                            "ce:given-name": "Chia-Jui",
                            "preferred-name": {
                                "ce:given-name": "Chia Jui",
                                "ce:initials": "C.J.",
                                "ce:surname": "Yen",
                                "ce:indexed-name": "Yen C.J."
                            },
                            "@seq": "13",
                            "@author-instance-id": "2003855381-d9a5f36f68dd75d2ad27b130c8cab8a5",
                            "ce:initials": "C.-J.",
                            "@date-locked": "2020-04-08T09:20:41.145",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yen",
                            "@auid": "56523917800",
                            "ce:indexed-name": "Yen C.-J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60073385",
                            "@country": "twn",
                            "city": "Taipei City",
                            "organization": [
                                {"$": "Department of Oncology"},
                                {"$": "National Taiwan University Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60073385",
                                "@dptid": "113273045"
                            },
                            "@affiliation-instance-id": "2003855381-c35759a1efdc5e48c2706942dfc22f19",
                            "ce:source-text": "Department of Oncology, National Taiwan University Hospital, Taipei City",
                            "@dptid": "113273045"
                        },
                        "author": [{
                            "ce:given-name": "Zhong-Zhe",
                            "preferred-name": {
                                "ce:given-name": "Zhong Zhe",
                                "ce:initials": "Z.Z.",
                                "ce:surname": "Lin",
                                "ce:indexed-name": "Lin Z.Z."
                            },
                            "@seq": "14",
                            "@author-instance-id": "2003855381-910ec92eeb8beffef40c13b327540970",
                            "ce:initials": "Z.-Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lin",
                            "@auid": "7404229651",
                            "ce:indexed-name": "Lin Z.-Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60006840",
                            "@country": "usa",
                            "city": "East Hanover",
                            "organization": [
                                {"$": "Translational Clinical Oncology"},
                                {"$": "Novartis Institutes for BioMedical Research"}
                            ],
                            "affiliation-id": {
                                "@afid": "60006840",
                                "@dptid": "115321404"
                            },
                            "state": "NJ",
                            "@affiliation-instance-id": "2003855381-356722332898a6392df298153229dc1b",
                            "ce:source-text": "Translational Clinical Oncology, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA",
                            "@dptid": "115321404"
                        },
                        "author": [{
                            "ce:given-name": "Luigi",
                            "preferred-name": {
                                "ce:given-name": "Luigi",
                                "ce:initials": "L.",
                                "ce:surname": "Manenti",
                                "ce:indexed-name": "Manenti L."
                            },
                            "@seq": "15",
                            "@author-instance-id": "2003855381-c31bdd27d7684808f27dad4a22ccc958",
                            "ce:initials": "L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Manenti",
                            "@auid": "57193268706",
                            "ce:indexed-name": "Manenti L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "117744602",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "PK Sciences"},
                                {"$": "China Novartis Institutes for BioMedical Research"}
                            ],
                            "affiliation-id": {"@afid": "117744602"},
                            "@affiliation-instance-id": "2003855381-50c238483361af8c1b4378d8ebf3267d",
                            "ce:source-text": "PK Sciences, China Novartis Institutes for BioMedical Research, Shanghai, China"
                        },
                        "author": [{
                            "ce:given-name": "Yi",
                            "preferred-name": {
                                "ce:given-name": "Yi",
                                "ce:initials": "Y.",
                                "ce:surname": "Gu",
                                "ce:indexed-name": "Gu Y."
                            },
                            "@seq": "16",
                            "@author-instance-id": "2003855381-774d387791c69dce2eace4f22deb128d",
                            "ce:initials": "Y.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Gu",
                            "@auid": "58382509900",
                            "ce:indexed-name": "Gu Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "117744602",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "Translational Clinical Oncology"},
                                {"$": "China Novartis Institutes for BioMedical Research"}
                            ],
                            "affiliation-id": {
                                "@afid": "117744602",
                                "@dptid": "123659963"
                            },
                            "@affiliation-instance-id": "2003855381-12f0733759d61082afbdca98256f879e",
                            "ce:source-text": "Translational Clinical Oncology, China Novartis Institutes for BioMedical Research, Shanghai, China",
                            "@dptid": "123659963"
                        },
                        "author": [
                            {
                                "ce:given-name": "Yongjian",
                                "preferred-name": {
                                    "ce:given-name": "Yongjian",
                                    "ce:initials": "Y.",
                                    "ce:surname": "Sun",
                                    "ce:indexed-name": "Sun Y."
                                },
                                "@seq": "17",
                                "@author-instance-id": "2003855381-d89e4f4577572ddd156b7bff2c4d0eb9",
                                "ce:initials": "Y.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sun",
                                "@auid": "57218148601",
                                "ce:indexed-name": "Sun Y."
                            },
                            {
                                "ce:given-name": "Lu",
                                "preferred-name": {
                                    "ce:given-name": "Lu",
                                    "ce:initials": "L.",
                                    "ce:surname": "Hao",
                                    "ce:indexed-name": "Hao L."
                                },
                                "@seq": "19",
                                "@author-instance-id": "2003855381-045ea916092c01263cc6cc91823dc9cb",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Hao",
                                "@auid": "57212379201",
                                "ce:indexed-name": "Hao L."
                            },
                            {
                                "ce:given-name": "Wenjie",
                                "preferred-name": {
                                    "ce:given-name": "Wenjie",
                                    "ce:initials": "W.",
                                    "ce:surname": "Song",
                                    "ce:indexed-name": "Song W."
                                },
                                "@seq": "20",
                                "@author-instance-id": "2003855381-b6eb6f9fa1e7cfbf4cb7ef91aeab5a59",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Song",
                                "@auid": "57212387603",
                                "ce:indexed-name": "Song W."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "@afid": "60009968",
                            "@country": "che",
                            "city": "Basel",
                            "organization": {"$": "Novartis Institutes for BioMedical Research"},
                            "affiliation-id": {"@afid": "60009968"},
                            "state": "Basel-Stadt",
                            "@affiliation-instance-id": "2003855381-b080f41d6307c21992006bd0c24e5aab",
                            "ce:source-text": "Novartis Institutes for BioMedical Research, Basel, Basel-Stadt, Switzerland"
                        },
                        "author": [{
                            "ce:given-name": "Ralph",
                            "preferred-name": {
                                "ce:given-name": "Ralph",
                                "ce:initials": "R.",
                                "ce:surname": "Tiedt",
                                "ce:indexed-name": "Tiedt R."
                            },
                            "@seq": "18",
                            "@author-instance-id": "2003855381-cc8cf8eeb70d37af1d98d212d46ff78c",
                            "ce:initials": "R.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tiedt",
                            "@auid": "8218941800",
                            "ce:indexed-name": "Tiedt R."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199575",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Gastroenterology"},
                                {"$": "Department of Medicine"},
                                {"$": "Siriraj Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199575",
                                    "@dptid": "125758157"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2003855381-db5a5dce4b29fb175314ae279ed8f1d0",
                            "ce:source-text": "Division of Gastroenterology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125758157"
                        },
                        "author": [{
                            "ce:given-name": "Tawesak",
                            "preferred-name": {
                                "ce:given-name": "Tawesak",
                                "ce:initials": "T.",
                                "ce:surname": "Tanwandee",
                                "ce:indexed-name": "Tanwandee T."
                            },
                            "@seq": "21",
                            "@author-instance-id": "2003855381-517c2e814ab6403b7565ea86e46b9f04",
                            "ce:initials": "T.",
                            "@date-locked": "2021-08-10T07:52:01.989",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tanwandee",
                            "@auid": "57042502500",
                            "ce:indexed-name": "Tanwandee T."
                        }]
                    }
                ],
                "citation-title": "A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma",
                "abstracts": "Â© The Author(s), 2019.Background: The objectives of this phase II study were to determine the clinical activity of the MET tyrosine kinase inhibitor capmatinib (INC280) in patients with MET-dysregulated advanced hepatocellular carcinoma (HCC) and to assess the safety, pharmacokinetics, and correlation of biomarkers with the response. Methods: This phase II, open-label, single-arm study evaluated twice daily (BID) oral capmatinib in a dose-determining stage, utilizing a Bayesian Logistic Regression Model (BLRM) subject to Escalation with Overdose Control criteria, safety, pharmacokinetics, and pharmacodynamic information to determine a recommended dose for expansion (RDE) evaluating efficacy in patients with MET-dysregulated HCC. Results: A total of 38 patients received treatment. In the dose-determining stage, patients received capmatinib 300 mg BID capsules (n = 8), and in the expansion, patients received 600 mg BID capsules (n = 28) or 400 mg BID tablets (n = 2) based on the BLRM and other relevant clinical data. No predefined qualifying adverse events (AEs) were observed during the first 28 days of treatment, and the RDE was 600 mg BID capsules (equivalent pharmacokinetics to 400 mg BID tablets). The most common any causality AEs were nausea (42%), vomiting (37%), and diarrhea (34%). In the expansion stage, in a subgroup of 10 patients with MET-high HCC, the overall response rate was 30%, including 1 durable complete response (>600 days) and 2 partial responses [1 durable (>600 days)]. Conclusions: Single agent capmatinib at the RDE is tolerable with a manageable safety profile. Antitumor activity was seen in a subset of patients with MET-dysregulated (MET-high) HCC. Trial registration: ClinicalTrials.gov: NCT01737827. https://clinicaltrials.gov/ct2/show/NCT01737827.",
                "correspondence": {
                    "affiliation": {
                        "country": "China",
                        "postal-code": "210002",
                        "@country": "chn",
                        "city": "Nanjing",
                        "organization": [
                            {"$": "PLA Cancer Center"},
                            {"$": "Nanjing Bayi Hospital"}
                        ],
                        "ce:source-text": "PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, 210002, China"
                    },
                    "person": {
                        "ce:given-name": "Shukui",
                        "ce:initials": "S.",
                        "ce:surname": "Qin",
                        "ce:indexed-name": "Qin S."
                    }
                },
                "related-item": {
                    "itemid": {
                        "$": "2004433418",
                        "@idtype": "erratumPUI"
                    },
                    "citation-title": "Erratum to A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma (Ther Adv Med Oncol, (2019), 11, (1-12), 10.1177/1758835919889001)",
                    "@type": "erratum",
                    "citation-info": {
                        "citation-type": {"@code": "er"},
                        "citation-language": {
                            "@language": "English",
                            "@xml:lang": "eng"
                        },
                        "abstract-language": {
                            "@language": "English",
                            "@xml:lang": "eng"
                        }
                    },
                    "source": {
                        "sourcetitle-abbrev": "Ther. Adv. Med. Oncol.",
                        "website": {"ce:e-address": {
                            "$": "http://tam.sagepub.com/content/by/year",
                            "@type": "email"
                        }},
                        "@country": "usa",
                        "translated-sourcetitle": {
                            "$": "Therapeutic Advances in Medical Oncology",
                            "@xml:lang": "eng"
                        },
                        "issn": [
                            {
                                "$": "17588359",
                                "@type": "electronic"
                            },
                            {
                                "$": "17588340",
                                "@type": "print"
                            }
                        ],
                        "volisspag": {"voliss": {"@volume": "12"}},
                        "@type": "j",
                        "publicationyear": {"@first": "2020"},
                        "publisher": {
                            "publishername": "SAGE Publications Inc.",
                            "ce:e-address": {
                                "$": "claims@sagepub.com",
                                "@type": "email"
                            }
                        },
                        "sourcetitle": "Therapeutic Advances in Medical Oncology",
                        "publicationdate": {"year": "2020"}
                    },
                    "ce:doi": "10.1177/1758835920913426"
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "capmatinib",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "HCC",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "INC280",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "MET inhibitor",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "phase II",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Ther. Adv. Med. Oncol.",
                    "website": {"ce:e-address": {
                        "$": "http://tam.sagepub.com/content/by/year",
                        "@type": "email"
                    }},
                    "@country": "usa",
                    "translated-sourcetitle": {
                        "$": "Therapeutic Advances in Medical Oncology",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "17588359",
                            "@type": "electronic"
                        },
                        {
                            "$": "17588340",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {"voliss": {"@volume": "11"}},
                    "@type": "j",
                    "publicationyear": {"@first": "2019"},
                    "publisher": {
                        "publishername": "SAGE Publications Inc.",
                        "ce:e-address": {
                            "$": "claims@sagepub.com",
                            "@type": "email"
                        }
                    },
                    "sourcetitle": "Therapeutic Advances in Medical Oncology",
                    "@srcid": "19700175160",
                    "publicationdate": {
                        "year": "2019",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2019"
                        }
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2730"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": [
                                    {"$": "9000-90-2"},
                                    {"$": "9000-92-4"},
                                    {"$": "9001-19-8"}
                                ],
                                "enzyme-commission-number": "EC 3.2.1.1",
                                "chemical-name": "amylase"
                            },
                            {
                                "cas-registry-number": "9000-97-9",
                                "enzyme-commission-number": "EC 2.6.1.1",
                                "chemical-name": "aspartate aminotransferase"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "18422-02-1"},
                                    {"$": "635-65-4"}
                                ],
                                "chemical-name": "bilirubin"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "1029712-80-8"},
                                    {"$": "1029714-89-3"},
                                    {"$": "1197376-85-4"},
                                    {"$": "1865733-40-9"}
                                ],
                                "chemical-name": "capmatinib"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "19230-81-0"},
                                    {"$": "60-27-5"}
                                ],
                                "chemical-name": "creatinine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "67256-21-7"},
                                    {"$": "72980-71-3"}
                                ],
                                "chemical-name": "scatter factor"
                            }
                        ]
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "Medical writing and editorial support for this manuscript was provided by Matthew Naylor PhD of Articulate Science and funded by Novartis Pharmaceuticals Corporation. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support for this study was provided by Novartis Pharmaceuticals Corporation.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "24",
                    "@year": "2020",
                    "@timestamp": "BST 07:35:40",
                    "@month": "03"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2003855381",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "922566261",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20190912066",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "2019430601",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20192553758",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20193722872",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2019001767617X",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85076565560",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85076565560",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1177/1758835919889001"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "30",
                "reference": [
                    {
                        "ref-fulltext": "Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018; 67: 358\u2013380.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "AASLD guidelines for the treatment of hepatocellular carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr1-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85038436844",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "358",
                                    "@last": "380"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Heimbach",
                                        "ce:indexed-name": "Heimbach J.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kulik",
                                        "ce:indexed-name": "Kulik L.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Finn",
                                        "ce:indexed-name": "Finn R.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018; 67: 358\u2013380."
                    },
                    {
                        "ref-fulltext": "Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69\u201390.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Global cancer statistics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr2-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79952232216",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "69",
                                    "@last": "90"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Jemal",
                                        "ce:indexed-name": "Jemal A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Bray",
                                        "ce:indexed-name": "Bray F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Center",
                                        "ce:indexed-name": "Center M.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CA Cancer J Clin"
                        },
                        "ce:source-text": "Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69\u201390."
                    },
                    {
                        "ref-fulltext": "Siegel R, Naishadham D, Jemal A., Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11\u201330.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Cancer statistics, 2013"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr3-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84872967522",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "11",
                                    "@last": "30"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Siegel",
                                    "ce:indexed-name": "Siegel R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Naishadham",
                                    "ce:indexed-name": "Naishadham D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jemal",
                                    "ce:indexed-name": "Jemal A."
                                }
                            ]},
                            "ref-sourcetitle": "CA Cancer J Clin"
                        },
                        "ce:source-text": "Siegel R, Naishadham D, Jemal A., Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11\u201330."
                    },
                    {
                        "ref-fulltext": "Qi XS, Guo XZ, Han GH, et al. MET inhibitors for treatment of advanced hepatocellular carcinoma: a review. World J Gastroenterol 2015; 21: 5445\u20135453.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "MET inhibitors for treatment of advanced hepatocellular carcinoma: a review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr4-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84929222885",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "5445",
                                    "@last": "5453"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Qi",
                                        "ce:indexed-name": "Qi X.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X.Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Guo",
                                        "ce:indexed-name": "Guo X.Z."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han G.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "World J Gastroenterol"
                        },
                        "ce:source-text": "Qi XS, Guo XZ, Han GH, et al. MET inhibitors for treatment of advanced hepatocellular carcinoma: a review. World J Gastroenterol 2015; 21: 5445\u20135453."
                    },
                    {
                        "ref-fulltext": "Ueki T, Fujimoto J, Suzuki T, et al. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology 1997; 25: 619\u2013623.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1997"},
                            "ref-title": {"ref-titletext": "Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr5-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0031044486",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "619",
                                    "@last": "623"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Ueki",
                                        "ce:indexed-name": "Ueki T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Fujimoto",
                                        "ce:indexed-name": "Fujimoto J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Suzuki",
                                        "ce:indexed-name": "Suzuki T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Ueki T, Fujimoto J, Suzuki T, et al. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology 1997; 25: 619\u2013623."
                    },
                    {
                        "ref-fulltext": "Kaposi-Novak P, Lee JS, GÃ²mez-Quiroz L, et al. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 2006; 116: 1582\u20131595.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr6-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33745220780",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "116"},
                                "pagerange": {
                                    "@first": "1582",
                                    "@last": "1595"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Kaposi-Novak",
                                        "ce:indexed-name": "Kaposi-Novak P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "GÃ²mez-Quiroz",
                                        "ce:indexed-name": "Gomez-Quiroz L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Invest"
                        },
                        "ce:source-text": "Kaposi-Novak P, Lee JS, GÃ²mez-Quiroz L, et al. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 2006; 116: 1582\u20131595."
                    },
                    {
                        "ref-fulltext": "Ke AW, Shi GM, Zhou J, et al. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 2009; 49: 491\u2013503.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr7-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "61949226823",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "49"},
                                "pagerange": {
                                    "@first": "491",
                                    "@last": "503"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Ke",
                                        "ce:indexed-name": "Ke A.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Shi",
                                        "ce:indexed-name": "Shi G.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "Ke AW, Shi GM, Zhou J, et al. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 2009; 49: 491\u2013503."
                    },
                    {
                        "ref-fulltext": "Osada S, Kanematsu M, Imai H, et al. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma. Hepatogastroenterology 2008; 55: 544\u2013549.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr8-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "44349155339",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "55"},
                                "pagerange": {
                                    "@first": "544",
                                    "@last": "549"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Osada",
                                        "ce:indexed-name": "Osada S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kanematsu",
                                        "ce:indexed-name": "Kanematsu M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Imai",
                                        "ce:indexed-name": "Imai H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatogastroenterology"
                        },
                        "ce:source-text": "Osada S, Kanematsu M, Imai H, et al. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma. Hepatogastroenterology 2008; 55: 544\u2013549."
                    },
                    {
                        "ref-fulltext": "Lee SJ, Lee J, Sohn I, et al. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma. Anticancer Res 2013; 33: 5179\u20135186.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr9-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84891370054",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "5179",
                                    "@last": "5186"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee S.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Sohn",
                                        "ce:indexed-name": "Sohn I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Anticancer Res"
                        },
                        "ce:source-text": "Lee SJ, Lee J, Sohn I, et al. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma. Anticancer Res 2013; 33: 5179\u20135186."
                    },
                    {
                        "ref-fulltext": "Liu X, Newton RC, Scherle PA., Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trends Mol Med 2010; 16: 37\u201345.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Developing c-MET pathway inhibitors for cancer therapy: progress and challenges"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr10-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "73449111266",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "37",
                                    "@last": "45"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu X."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Newton",
                                    "ce:indexed-name": "Newton R.C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Scherle",
                                    "ce:indexed-name": "Scherle P.A."
                                }
                            ]},
                            "ref-sourcetitle": "Trends Mol Med"
                        },
                        "ce:source-text": "Liu X, Newton RC, Scherle PA., Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trends Mol Med 2010; 16: 37\u201345."
                    },
                    {
                        "ref-fulltext": "Sierra JR, Tsao MS., c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol 2011; 3(Suppl. 1): S21\u2013S35.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "c-MET as a potential therapeutic target and biomarker in cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr11-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84997909291",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "S21",
                                    "@last": "S35"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Sierra",
                                    "ce:indexed-name": "Sierra J.R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Tsao",
                                    "ce:indexed-name": "Tsao M.S."
                                }
                            ]},
                            "ref-sourcetitle": "Ther Adv Med Oncol"
                        },
                        "ce:source-text": "Sierra JR, Tsao MS., c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol 2011; 3(Suppl. 1): S21\u2013S35."
                    },
                    {
                        "ref-fulltext": "You H, Ding W, Dang H, et al. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology 2011; 54: 879\u2013889.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr12-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80052033164",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "54"},
                                "pagerange": {
                                    "@first": "879",
                                    "@last": "889"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "You",
                                        "ce:indexed-name": "You H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Ding",
                                        "ce:indexed-name": "Ding W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Dang",
                                        "ce:indexed-name": "Dang H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hepatology"
                        },
                        "ce:source-text": "You H, Ding W, Dang H, et al. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology 2011; 54: 879\u2013889."
                    },
                    {
                        "ref-fulltext": "Xie Q, Su Y, Dykema K, et al. Overexpression of HGF promotes HBV-induced hepatocellular carcinoma progression and is an effective indicator for MET-targeting therapy. Genes Cancer 2013; 4: 247\u2013260.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Overexpression of HGF promotes HBV-induced hepatocellular carcinoma progression and is an effective indicator for MET-targeting therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr13-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84887414585",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "247",
                                    "@last": "260"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Xie",
                                        "ce:indexed-name": "Xie Q."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Su",
                                        "ce:indexed-name": "Su Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Dykema",
                                        "ce:indexed-name": "Dykema K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Genes Cancer"
                        },
                        "ce:source-text": "Xie Q, Su Y, Dykema K, et al. Overexpression of HGF promotes HBV-induced hepatocellular carcinoma progression and is an effective indicator for MET-targeting therapy. Genes Cancer 2013; 4: 247\u2013260."
                    },
                    {
                        "ref-fulltext": "Liu X, Wang Q, Yang G, et al. A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3. Clin Cancer Res 2011; 17: 7127\u20137138.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr14-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "81255138189",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "7127",
                                    "@last": "7138"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang Q."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Liu X, Wang Q, Yang G, et al. A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3. Clin Cancer Res 2011; 17: 7127\u20137138."
                    },
                    {
                        "ref-fulltext": "Ma B, Bang Y, Lim D, et al. Phase I dose-escalation and -expansion study to evaluate safety and efficacy of capmatinib (INC280) in patients with advanced MET-dependent solid tumors. In: Targeted Anticancer Therapies, Paris, France, 2\u20134 March 2015, poster P1.04.",
                        "@id": "15",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr15-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076513435",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Targeted Anticancer Therapies, Paris, France, 2\u20134 March 2015, In:, poster P1.04",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Ma",
                                        "ce:indexed-name": "Ma B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Bang",
                                        "ce:indexed-name": "Bang Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Phase I dose-escalation and -expansion study to evaluate safety and efficacy of capmatinib (INC280) in patients with advanced MET-dependent solid tumors"
                        },
                        "ce:source-text": "Ma B, Bang Y, Lim D, et al. Phase I dose-escalation and -expansion study to evaluate safety and efficacy of capmatinib (INC280) in patients with advanced MET-dependent solid tumors. In: Targeted Anticancer Therapies, Paris, France, 2\u20134 March 2015, poster P1.04."
                    },
                    {
                        "ref-fulltext": "Schuler MH, Berardi R, Lim W, et al. Phase (Ph) I study of the safety and efficacy of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced cMET+ non-small cell lung cancer (NSCLC). J Clin Oncol 2016; 34(Suppl.): abstract 9067.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Phase (Ph) I study of the safety and efficacy of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced cMET+ non-small cell lung cancer (NSCLC)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr16-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84998784792",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "34"}},
                            "ref-text": "(,): abstract 9067",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Schuler",
                                        "ce:indexed-name": "Schuler M.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Berardi",
                                        "ce:indexed-name": "Berardi R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Schuler MH, Berardi R, Lim W, et al. Phase (Ph) I study of the safety and efficacy of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced cMET+ non-small cell lung cancer (NSCLC). J Clin Oncol 2016; 34(Suppl.): abstract 9067."
                    },
                    {
                        "ref-fulltext": "Bang YJ, Su WC, Nam DH, et al. Phase I study of the safety and efficacy of INC280 in patients with advanced MET-dependent solid tumors. J Clin Oncol 2014; 32(Suppl. 15): abstract 2520.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Phase I study of the safety and efficacy of INC280 in patients with advanced MET-dependent solid tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr17-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84914179300",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "32"}},
                            "ref-text": "(,): abstract 2520",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bang",
                                        "ce:indexed-name": "Bang Y.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Su",
                                        "ce:indexed-name": "Su W.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Nam",
                                        "ce:indexed-name": "Nam D.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Bang YJ, Su WC, Nam DH, et al. Phase I study of the safety and efficacy of INC280 in patients with advanced MET-dependent solid tumors. J Clin Oncol 2014; 32(Suppl. 15): abstract 2520."
                    },
                    {
                        "ref-fulltext": "Wu Y, Yang JC, Kim D, et al. Safety and efficacy of INC280 in combination with gefitinib (gef) in patients with EGFR-mutated (mut), MET-positive NSCLC: a single-arm phase Ib/II study. J Clin Oncol 2014; 32(Suppl. 15): abstract 8017.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Safety and efficacy of INC280 in combination with gefitinib (gef) in patients with EGFR-mutated (mut), MET-positive NSCLC: a single-arm phase Ib/II study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr18-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84907561441",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "32"}},
                            "ref-text": "(,): abstract 8017",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang J.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Wu Y, Yang JC, Kim D, et al. Safety and efficacy of INC280 in combination with gefitinib (gef) in patients with EGFR-mutated (mut), MET-positive NSCLC: a single-arm phase Ib/II study. J Clin Oncol 2014; 32(Suppl. 15): abstract 8017."
                    },
                    {
                        "ref-fulltext": "Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378\u2013390.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Sorafenib in advanced hepatocellular carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr19-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "47949116252",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {
                                    "@first": "378",
                                    "@last": "390"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Llovet",
                                        "ce:indexed-name": "Llovet J.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ricci",
                                        "ce:indexed-name": "Ricci S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Mazzaferro",
                                        "ce:indexed-name": "Mazzaferro V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378\u2013390."
                    },
                    {
                        "ref-fulltext": "Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009; 10: 25\u201334.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr20-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "57749189578",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "25",
                                    "@last": "34"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Cheng",
                                        "ce:indexed-name": "Cheng A.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Kang",
                                        "ce:indexed-name": "Kang Y.K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen Z."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009; 10: 25\u201334."
                    },
                    {
                        "ref-fulltext": "Bruix J, Qin S, Merle P, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2017; 389: 56\u201366.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr21-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85007560261",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "389"},
                                "pagerange": {
                                    "@first": "56",
                                    "@last": "66"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bruix",
                                        "ce:indexed-name": "Bruix J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Qin",
                                        "ce:indexed-name": "Qin S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Merle",
                                        "ce:indexed-name": "Merle P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Bruix J, Qin S, Merle P, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2017; 389: 56\u201366."
                    },
                    {
                        "ref-fulltext": "El-Khoueiry AB, Sangro B, Yau T, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 2017; 389: 2492\u20132502.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr22-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85018660134",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "389"},
                                "pagerange": {
                                    "@first": "2492",
                                    "@last": "2502"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.B.",
                                        "@_fa": "true",
                                        "ce:surname": "El-Khoueiry",
                                        "ce:indexed-name": "El-Khoueiry A.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Sangro",
                                        "ce:indexed-name": "Sangro B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yau",
                                        "ce:indexed-name": "Yau T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "El-Khoueiry AB, Sangro B, Yau T, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 2017; 389: 2492\u20132502."
                    },
                    {
                        "ref-fulltext": "OPDIVO (nivolumab) injection prescribing information, www.accessdata.fda.gov/drugsatfda_docs/label/2017/125554s041lbl.pdf (2017, accessed 14 March 2018).",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "www.accessdata.fda.gov/drugsatfda_docs/label/2017/125554s041lbl.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr23-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076510103",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "accessed 14 March 2018",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "OPDIVO (nivolumab) injection prescribing information",
                                "ce:indexed-name": "OPDIVO (nivolumab) injection prescribing information"
                            }}
                        },
                        "ce:source-text": "OPDIVO (nivolumab) injection prescribing information, www.accessdata.fda.gov/drugsatfda_docs/label/2017/125554s041lbl.pdf (2017, accessed 14 March 2018)."
                    },
                    {
                        "ref-fulltext": "Qin S, Kim T, Lim HY, et al. Final data from a phase Ib trial of tepotinib in Asian patients with advanced hepatocellular carcinoma (HCC). Ann Oncol 2017; 28(Suppl. 5): abstract 701P.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Final data from a phase Ib trial of tepotinib in Asian patients with advanced hepatocellular carcinoma (HCC)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr24-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076569762",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "28"}},
                            "ref-text": "(,): abstract 701P",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Qin",
                                        "ce:indexed-name": "Qin S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim H.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Qin S, Kim T, Lim HY, et al. Final data from a phase Ib trial of tepotinib in Asian patients with advanced hepatocellular carcinoma (HCC). Ann Oncol 2017; 28(Suppl. 5): abstract 701P."
                    },
                    {
                        "ref-fulltext": "Qin S, Kim TY, Lim HY, et al. Phase Ib trial of tepotinib in Asian patients with advanced hepatocellular carcinoma (HCC): final data including long-term outcomes. J Clin Oncol 2017; 35(Suppl. 15): abstract 4087.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Phase Ib trial of tepotinib in Asian patients with advanced hepatocellular carcinoma (HCC): final data including long-term outcomes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr25-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85029913206",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {"@first": "4087"}
                            },
                            "ref-text": "(,): abstract",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Qin",
                                        "ce:indexed-name": "Qin S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim T.Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim H.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Qin S, Kim TY, Lim HY, et al. Phase Ib trial of tepotinib in Asian patients with advanced hepatocellular carcinoma (HCC): final data including long-term outcomes. J Clin Oncol 2017; 35(Suppl. 15): abstract 4087."
                    },
                    {
                        "ref-fulltext": "Rimassa L, Assenat E, Peck-Radosavljevic M, et al. Second-line tivantinib (ARQ 197) versus placebo in patients with MET-high hepatocellular carcinoma (HCC): results of the METIV-HCC phase III trial. J Clin Oncol 2017; 35(Suppl. 15): abstract 4000.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Second-line tivantinib (ARQ 197) versus placebo in patients with MET-high hepatocellular carcinoma (HCC): results of the METIV-HCC phase III trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr26-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85029939047",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "35"}},
                            "ref-text": "(,): abstract 4000",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Rimassa",
                                        "ce:indexed-name": "Rimassa L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Assenat",
                                        "ce:indexed-name": "Assenat E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Peck-Radosavljevic",
                                        "ce:indexed-name": "Peck-Radosavljevic M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Rimassa L, Assenat E, Peck-Radosavljevic M, et al. Second-line tivantinib (ARQ 197) versus placebo in patients with MET-high hepatocellular carcinoma (HCC): results of the METIV-HCC phase III trial. J Clin Oncol 2017; 35(Suppl. 15): abstract 4000."
                    },
                    {
                        "ref-fulltext": "Best J, Schotten C, Lohmann G, et al. Tivantinib for the treatment of hepatocellular carcinoma. Expert Opin Pharmacother 2017; 18: 727\u2013733.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Tivantinib for the treatment of hepatocellular carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr27-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85017505725",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "727",
                                    "@last": "733"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Best",
                                        "ce:indexed-name": "Best J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Schotten",
                                        "ce:indexed-name": "Schotten C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Lohmann",
                                        "ce:indexed-name": "Lohmann G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Expert Opin Pharmacother"
                        },
                        "ce:source-text": "Best J, Schotten C, Lohmann G, et al. Tivantinib for the treatment of hepatocellular carcinoma. Expert Opin Pharmacother 2017; 18: 727\u2013733."
                    },
                    {
                        "ref-fulltext": "Rebouissou S, La Bella T, Rekik S, et al. Proliferation markers are associated with MET expression in hepatocellular carcinoma and predict tivantinib sensitivity in vitro. Clin Cancer Res 2017; 23: 4364\u20134375.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Proliferation markers are associated with MET expression in hepatocellular carcinoma and predict tivantinib sensitivity in vitro"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr28-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85017880970",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "4364",
                                    "@last": "4375"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rebouissou",
                                        "ce:indexed-name": "Rebouissou S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "La Bella",
                                        "ce:indexed-name": "La Bella T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rekik",
                                        "ce:indexed-name": "Rekik S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Rebouissou S, La Bella T, Rekik S, et al. Proliferation markers are associated with MET expression in hepatocellular carcinoma and predict tivantinib sensitivity in vitro. Clin Cancer Res 2017; 23: 4364\u20134375."
                    },
                    {
                        "ref-fulltext": "Lu S, TÃ¶rÃ¶k HP, Gallmeier E, et al. Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1. Oncotarget 2015; 6: 22167\u201322178.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr29-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84941248867",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "22167",
                                    "@last": "22178"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.P.",
                                        "@_fa": "true",
                                        "ce:surname": "TÃ¶rÃ¶k",
                                        "ce:indexed-name": "Torok H.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Gallmeier",
                                        "ce:indexed-name": "Gallmeier E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Lu S, TÃ¶rÃ¶k HP, Gallmeier E, et al. Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1. Oncotarget 2015; 6: 22167\u201322178."
                    },
                    {
                        "ref-fulltext": "Muller PA, Trinidad AG, Timpson P, et al. Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion. Oncogene 2013; 32: 1252\u20131265.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bibr30-1758835919889001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84874786083",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "32"},
                                "pagerange": {
                                    "@first": "1252",
                                    "@last": "1265"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Muller",
                                        "ce:indexed-name": "Muller P.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Trinidad",
                                        "ce:indexed-name": "Trinidad A.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Timpson",
                                        "ce:indexed-name": "Timpson P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncogene"
                        },
                        "ce:source-text": "Muller PA, Trinidad AG, Timpson P, et al. Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion. Oncogene 2013; 32: 1252\u20131265."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Shanghai",
            "@id": "117744602",
            "affilname": "China Novartis Institutes for BioMedical Research",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117744602",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hangzhou",
            "@id": "60118427",
            "affilname": "Sir Run Run Shaw Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118427",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60088470",
            "affilname": "307 Hospital of PLA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60088470",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60082502",
            "affilname": "Sun Yat-Sen University Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Tainan",
            "@id": "60073386",
            "affilname": "National Cheng Kung University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073386",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Xi'an",
            "@id": "60069708",
            "affilname": "Xijing Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069708",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60031809",
            "affilname": "National Cancer Centre, Singapore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60024787",
            "affilname": "Prince of Wales Hospital Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024787",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60017165",
            "affilname": "Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Basel",
            "@id": "60009968",
            "affilname": "Novartis International AG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60009860",
            "affilname": "Fudan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009860",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Cambridge",
            "@id": "60006840",
            "affilname": "Novartis Institutes for BioMedical Research, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006840",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60006541",
            "affilname": "The University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60002593",
            "affilname": "Southern Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002593",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Nanjing",
            "@id": "100642684",
            "affilname": "Nanjing Bayi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100642684",
            "affiliation-country": "China"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85076565560",
        "dc:description": "Background: The objectives of this phase II study were to determine the clinical activity of the MET tyrosine kinase inhibitor capmatinib (INC280) in patients with MET-dysregulated advanced hepatocellular carcinoma (HCC) and to assess the safety, pharmacokinetics, and correlation of biomarkers with the response. Methods: This phase II, open-label, single-arm study evaluated twice daily (BID) oral capmatinib in a dose-determining stage, utilizing a Bayesian Logistic Regression Model (BLRM) subject to Escalation with Overdose Control criteria, safety, pharmacokinetics, and pharmacodynamic information to determine a recommended dose for expansion (RDE) evaluating efficacy in patients with MET-dysregulated HCC. Results: A total of 38 patients received treatment. In the dose-determining stage, patients received capmatinib 300 mg BID capsules (n = 8), and in the expansion, patients received 600 mg BID capsules (n = 28) or 400 mg BID tablets (n = 2) based on the BLRM and other relevant clinical data. No predefined qualifying adverse events (AEs) were observed during the first 28 days of treatment, and the RDE was 600 mg BID capsules (equivalent pharmacokinetics to 400 mg BID tablets). The most common any causality AEs were nausea (42%), vomiting (37%), and diarrhea (34%). In the expansion stage, in a subgroup of 10 patients with MET-high HCC, the overall response rate was 30%, including 1 durable complete response (>600 days) and 2 partial responses [1 durable (>600 days)]. Conclusions: Single agent capmatinib at the RDE is tolerable with a manageable safety profile. Antitumor activity was seen in a subset of patients with MET-dysregulated (MET-high) HCC. Trial registration: ClinicalTrials.gov: NCT01737827. https://clinicaltrials.gov/ct2/show/NCT01737827.",
        "prism:coverDate": "2019-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85076565560",
        "subtypeDescription": "Article",
        "dc:creator": {"author": [{
            "ce:given-name": "Shukui",
            "preferred-name": {
                "ce:given-name": "Shukui",
                "ce:initials": "S.",
                "ce:surname": "Qin",
                "ce:indexed-name": "Qin S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "100642684",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100642684"
            },
            "ce:surname": "Qin",
            "@auid": "57217457374",
            "author-url": "https://api.elsevier.com/content/author/author_id/57217457374",
            "ce:indexed-name": "Qin S."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85076565560"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076565560&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85076565560&origin=inward"
            }
        ],
        "prism:publicationName": "Therapeutic Advances in Medical Oncology",
        "source-id": "19700175160",
        "citedby-count": "35",
        "prism:volume": "11",
        "subtype": "ar",
        "dc:title": "A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma",
        "openaccess": "1",
        "openaccessFlag": "true",
        "prism:doi": "10.1177/1758835919889001",
        "prism:issn": "17588359 17588340",
        "publishercopyright": "Â© The Author(s), 2019.",
        "dc:identifier": "SCOPUS_ID:85076565560",
        "dc:publisher": "SAGE Publications Inc.claims@sagepub.com"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "capmatinib"
        },
        {
            "@_fa": "true",
            "$": "HCC"
        },
        {
            "@_fa": "true",
            "$": "INC280"
        },
        {
            "@_fa": "true",
            "$": "MET inhibitor"
        },
        {
            "@_fa": "true",
            "$": "phase II"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Oncology",
        "@code": "2730",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Shukui",
            "preferred-name": {
                "ce:given-name": "Shukui",
                "ce:initials": "S.",
                "ce:surname": "Qin",
                "ce:indexed-name": "Qin S."
            },
            "@seq": "1",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "100642684",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100642684"
            },
            "ce:surname": "Qin",
            "@auid": "57217457374",
            "author-url": "https://api.elsevier.com/content/author/author_id/57217457374",
            "ce:indexed-name": "Qin S."
        },
        {
            "ce:given-name": "Stephen Lam",
            "preferred-name": {
                "ce:given-name": "Stephen Lam",
                "ce:initials": "S.L.",
                "ce:surname": "Chan",
                "ce:indexed-name": "Chan S.L."
            },
            "@seq": "2",
            "ce:initials": "S.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60024787",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024787"
            },
            "ce:surname": "Chan",
            "@auid": "34973871600",
            "author-url": "https://api.elsevier.com/content/author/author_id/34973871600",
            "ce:indexed-name": "Chan S.L."
        },
        {
            "ce:given-name": "Wattana",
            "preferred-name": {
                "ce:given-name": "Wattana",
                "ce:initials": "W.",
                "ce:surname": "Sukeepaisarnjaroen",
                "ce:indexed-name": "Sukeepaisarnjaroen W."
            },
            "@seq": "3",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017165",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165"
            },
            "ce:surname": "Sukeepaisarnjaroen",
            "@auid": "6505802234",
            "author-url": "https://api.elsevier.com/content/author/author_id/6505802234",
            "ce:indexed-name": "Sukeepaisarnjaroen W."
        },
        {
            "ce:given-name": "Guohong",
            "preferred-name": {
                "ce:given-name": "Guohong",
                "ce:initials": "G.",
                "ce:surname": "Han",
                "ce:indexed-name": "Han G."
            },
            "@seq": "4",
            "ce:initials": "G.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60069708",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069708"
            },
            "ce:surname": "Han",
            "@auid": "24741087200",
            "author-url": "https://api.elsevier.com/content/author/author_id/24741087200",
            "ce:indexed-name": "Han G."
        },
        {
            "ce:given-name": "Su Pin",
            "preferred-name": {
                "ce:given-name": "Su Pin",
                "ce:initials": "S.P.",
                "ce:surname": "Choo",
                "ce:indexed-name": "Choo S.P."
            },
            "@seq": "5",
            "ce:initials": "S.P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031809",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809"
            },
            "ce:surname": "Choo",
            "@auid": "12446713500",
            "author-url": "https://api.elsevier.com/content/author/author_id/12446713500",
            "ce:indexed-name": "Choo S.P."
        },
        {
            "ce:given-name": "Virote",
            "preferred-name": {
                "ce:given-name": "Virote",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "6",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "ce:given-name": "Hongming",
            "preferred-name": {
                "ce:given-name": "Hongming",
                "ce:initials": "H.",
                "ce:surname": "Pan",
                "ce:indexed-name": "Pan H."
            },
            "@seq": "7",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60118427",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118427"
            },
            "ce:surname": "Pan",
            "@auid": "57202595746",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202595746",
            "ce:indexed-name": "Pan H."
        },
        {
            "ce:given-name": "Thomas",
            "preferred-name": {
                "ce:given-name": "Thomas",
                "ce:initials": "T.",
                "ce:surname": "Yau",
                "ce:indexed-name": "Yau T."
            },
            "@seq": "8",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006541",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541"
            },
            "ce:surname": "Yau",
            "@auid": "23391533100",
            "author-url": "https://api.elsevier.com/content/author/author_id/23391533100",
            "ce:indexed-name": "Yau T."
        },
        {
            "ce:given-name": "Yabing",
            "preferred-name": {
                "ce:given-name": "Yabing",
                "ce:initials": "Y.",
                "ce:surname": "Guo",
                "ce:indexed-name": "Guo Y."
            },
            "@seq": "9",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002593",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002593"
            },
            "ce:surname": "Guo",
            "@auid": "55612247400",
            "author-url": "https://api.elsevier.com/content/author/author_id/55612247400",
            "ce:indexed-name": "Guo Y."
        },
        {
            "ce:given-name": "Minshan",
            "preferred-name": {
                "ce:given-name": "Minshan",
                "ce:initials": "M.",
                "ce:surname": "Chen",
                "ce:indexed-name": "Chen M."
            },
            "@seq": "10",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60082502",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502"
            },
            "ce:surname": "Chen",
            "@auid": "24333976200",
            "author-url": "https://api.elsevier.com/content/author/author_id/24333976200",
            "ce:indexed-name": "Chen M."
        },
        {
            "ce:given-name": "Zhenggang",
            "preferred-name": {
                "ce:given-name": "Zhenggang",
                "ce:initials": "Z.",
                "ce:surname": "Ren",
                "ce:indexed-name": "Ren Z."
            },
            "@seq": "11",
            "ce:initials": "Z.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009860",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009860"
            },
            "ce:surname": "Ren",
            "@auid": "7402408571",
            "author-url": "https://api.elsevier.com/content/author/author_id/7402408571",
            "ce:indexed-name": "Ren Z."
        },
        {
            "ce:given-name": "Jianming",
            "preferred-name": {
                "ce:given-name": "Jianming",
                "ce:initials": "J.",
                "ce:surname": "Xu",
                "ce:indexed-name": "Xu J."
            },
            "@seq": "12",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60088470",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60088470"
            },
            "ce:surname": "Xu",
            "@auid": "57196733111",
            "author-url": "https://api.elsevier.com/content/author/author_id/57196733111",
            "ce:indexed-name": "Xu J."
        },
        {
            "ce:given-name": "Chia-Jui",
            "preferred-name": {
                "ce:given-name": "Chia Jui",
                "ce:initials": "C.J.",
                "ce:surname": "Yen",
                "ce:indexed-name": "Yen C.J."
            },
            "@seq": "13",
            "ce:initials": "C.-J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073386",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073386"
            },
            "ce:surname": "Yen",
            "@auid": "56523917800",
            "author-url": "https://api.elsevier.com/content/author/author_id/56523917800",
            "ce:indexed-name": "Yen C.-J."
        },
        {
            "ce:given-name": "Zhong-Zhe",
            "preferred-name": {
                "ce:given-name": "Zhong Zhe",
                "ce:initials": "Z.Z.",
                "ce:surname": "Lin",
                "ce:indexed-name": "Lin Z.Z."
            },
            "@seq": "14",
            "ce:initials": "Z.-Z.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073385",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385"
            },
            "ce:surname": "Lin",
            "@auid": "7404229651",
            "author-url": "https://api.elsevier.com/content/author/author_id/7404229651",
            "ce:indexed-name": "Lin Z.-Z."
        },
        {
            "ce:given-name": "Luigi",
            "preferred-name": {
                "ce:given-name": "Luigi",
                "ce:initials": "L.",
                "ce:surname": "Manenti",
                "ce:indexed-name": "Manenti L."
            },
            "@seq": "15",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006840",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006840"
            },
            "ce:surname": "Manenti",
            "@auid": "57193268706",
            "author-url": "https://api.elsevier.com/content/author/author_id/57193268706",
            "ce:indexed-name": "Manenti L."
        },
        {
            "ce:given-name": "Yi",
            "preferred-name": {
                "ce:given-name": "Yi",
                "ce:initials": "Y.",
                "ce:surname": "Gu",
                "ce:indexed-name": "Gu Y."
            },
            "@seq": "16",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "117744602",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117744602"
            },
            "ce:surname": "Gu",
            "@auid": "58382509900",
            "author-url": "https://api.elsevier.com/content/author/author_id/58382509900",
            "ce:indexed-name": "Gu Y."
        },
        {
            "ce:given-name": "Yongjian",
            "preferred-name": {
                "ce:given-name": "Yongjian",
                "ce:initials": "Y.",
                "ce:surname": "Sun",
                "ce:indexed-name": "Sun Y."
            },
            "@seq": "17",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "117744602",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117744602"
            },
            "ce:surname": "Sun",
            "@auid": "57218148601",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218148601",
            "ce:indexed-name": "Sun Y."
        },
        {
            "ce:given-name": "Ralph",
            "preferred-name": {
                "ce:given-name": "Ralph",
                "ce:initials": "R.",
                "ce:surname": "Tiedt",
                "ce:indexed-name": "Tiedt R."
            },
            "@seq": "18",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Tiedt",
            "@auid": "8218941800",
            "author-url": "https://api.elsevier.com/content/author/author_id/8218941800",
            "ce:indexed-name": "Tiedt R."
        },
        {
            "ce:given-name": "Lu",
            "preferred-name": {
                "ce:given-name": "Lu",
                "ce:initials": "L.",
                "ce:surname": "Hao",
                "ce:indexed-name": "Hao L."
            },
            "@seq": "19",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "117744602",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117744602"
            },
            "ce:surname": "Hao",
            "@auid": "57212379201",
            "author-url": "https://api.elsevier.com/content/author/author_id/57212379201",
            "ce:indexed-name": "Hao L."
        },
        {
            "ce:given-name": "Wenjie",
            "preferred-name": {
                "ce:given-name": "Wenjie",
                "ce:initials": "W.",
                "ce:surname": "Song",
                "ce:indexed-name": "Song W."
            },
            "@seq": "20",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "117744602",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117744602"
            },
            "ce:surname": "Song",
            "@auid": "57212387603",
            "author-url": "https://api.elsevier.com/content/author/author_id/57212387603",
            "ce:indexed-name": "Song W."
        },
        {
            "ce:given-name": "Tawesak",
            "preferred-name": {
                "ce:given-name": "Tawesak",
                "ce:initials": "T.",
                "ce:surname": "Tanwandee",
                "ce:indexed-name": "Tanwandee T."
            },
            "@seq": "21",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:surname": "Tanwandee",
            "@auid": "57042502500",
            "author-url": "https://api.elsevier.com/content/author/author_id/57042502500",
            "ce:indexed-name": "Tanwandee T."
        }
    ]}
}}